Breaking News
August 15, 2018 - Real-time dynamic monitoring of cell’s nucleus for effective cancer screening
August 15, 2018 - Lower rates of Medicare preventive care visits found in racial, ethnic minority older adults
August 15, 2018 - Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia
August 15, 2018 - Cytoplan introduces three new nutritional supplements
August 15, 2018 - Effective hemorrhage control critical for survival after motorsport accidents
August 15, 2018 - Sygnature Discovery announces ambitious expansion plan with addition of Alderley Park facility
August 15, 2018 - Dietary carbohydrates could lead to osteoarthritis, new study finds
August 15, 2018 - Male tobacco smokers have decreased number of cannabinoid CB1 receptors, study reveals
August 15, 2018 - Scientists explore ways for drug therapies to reach deadly brain tumors
August 15, 2018 - Rethinking fundamental rule of stroke care: ‘Time is brain!’
August 15, 2018 - Scientists reveal role of ‘junk DNA’ in cancer dissemination
August 15, 2018 - Google’s DeepMind AI could soon be diagnosing eye conditions
August 15, 2018 - Scientists trick the brain to embody the prosthetic limb
August 15, 2018 - Researchers focus on uncoupling obesity from diabetes
August 15, 2018 - A class of proteins shown to be effective in reducing drug-seeking behaviors
August 15, 2018 - Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
August 15, 2018 - Rheumatoid arthritis in pregnancy associated with low birth weight and premature birth
August 15, 2018 - Study may help increase effectiveness of antibiotics against drug-resistant bacteria
August 15, 2018 - Analyzing resident-to-resident incidents in dementia may hold the key to reducing future fatalities
August 15, 2018 - Robotic walking frame aims to help maintain mobility of older adults
August 15, 2018 - Simple intervention during routine care reduces alcohol consumption in men with HIV
August 15, 2018 - Genetics Home Reference: gout
August 15, 2018 - Scientists ID genesis of disease, focus efforts on shape-shifting tau
August 15, 2018 - OncoThira and NDSU enter into license agreement to develop, market cancer compounds
August 15, 2018 - Scientists unravel the mystery behind ovarian cancer with high-grade serous carcinoma
August 15, 2018 - Common signs that indicate vision problems in children
August 15, 2018 - Removing the cancer label – overhaul in cancer classification proposed
August 15, 2018 - Prams may expose babies and toddlers to more air pollution finds study
August 15, 2018 - Duke researchers track missing T-cells in glioblastoma patients
August 15, 2018 - Cardiac Profiles Up With Exercise, Less Sitting in Early Old Age
August 15, 2018 - Precision medicine offers a glimmer of hope for Alzheimer’s disease
August 15, 2018 - Immunovia’s new blood-based testing platform accurately detects non-small cell lung cancer
August 15, 2018 - New method provides a ‘big picture’ of genetic influences on traits and diseases
August 15, 2018 - Early Onset Type 1 Diabetes Linked to Heart Disease, Shorter Life
August 14, 2018 - SMURF1 provides targeted approach to preventing cocaine addiction relapse
August 14, 2018 - Genetic testing pushed for hereditary high cholesterol disease
August 14, 2018 - Researchers discover new genes involved in Alzheimer’s Disease
August 14, 2018 - Medicare to overhaul ACOs but critics fear fewer participants
August 14, 2018 - Adolescent health projects receive meager percentage of global funding, study finds
August 14, 2018 - University Hospitals Seidman Cancer Center launches new CAR-T therapy trial
August 14, 2018 - In the addiction battle, is forced rehab the solution?
August 14, 2018 - Busting myths about milk – Scope
August 14, 2018 - Platelet-rich plasma does not enhance cartilage formation capabilities of stem cells
August 14, 2018 - Wearable devices and ‘mhealth’ technology emerge as promising tools for better health
August 14, 2018 - Johns Hopkins expert panel develops first set of operation-specific opioid prescribing guidelines
August 14, 2018 - Clinical study suggests new treatment direction for head and neck cancer in heavy smokers
August 14, 2018 - Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved Gut Microbiome of Patients with CDI
August 14, 2018 - Cardiac progenitor cells undergo a cell fate switch to build coronary arteries
August 14, 2018 - Study identifies potential guidance to treat gastric cancer patients
August 14, 2018 - Revealed: The molecular mechanism underlying hypertrophic cardiomyopathy, or “workaholic heart”
August 14, 2018 - Diabetes epidemic in Guatemala driven by aging, not obesity
August 14, 2018 - New technology shows potential to streamline the analysis of proteins
August 14, 2018 - Rethinking the stroke rule ‘time is brain’
August 14, 2018 - Incidence of coronary artery compression in children may be more common than previously thought
August 14, 2018 - Study helps to better understand disease caused by Alpha-1 antitrypsin deficiency
August 14, 2018 - AI platform identifies acute neurological illnesses faster than human diagnosis
August 14, 2018 - American College of Rheumatology receives grants to support development of lupus clinical trials
August 14, 2018 - New study explains why women get more migraines than men
August 14, 2018 - American Heart Association Urges Screen Time Limits for Youth
August 14, 2018 - Brief interventions during routine care reduce alcohol use among men with HIV
August 14, 2018 - New genome analysis could identify people at higher risk of common deadly diseases
August 14, 2018 - NIH grant for Mount Sinai to study use of inhaled corticosteroids for treatment of sickle cell disease
August 14, 2018 - Daicel supplies free nanodiamond samples to international researchers
August 14, 2018 - Switching anti-psychotic drugs in first-episode schizophrenia patients does not improve clinical outcomes
August 14, 2018 - Study to examine whether modulating gut bacteria can improve cardiac function in heart failure patients
August 14, 2018 - AI technology could hold key to improving health services
August 14, 2018 - One out of two children not getting enough nutrients needed for their health
August 14, 2018 - Mono-antiplatelet therapy after aortic heart valve replacements may work as well as two drugs
August 14, 2018 - Aid-in-dying patient chooses his last day
August 14, 2018 - Exercise Really Can Chase Away the Blues, to a Point
August 14, 2018 - Surgical mesh implants may cause autoimmune disorders
August 14, 2018 - Researchers develop revolutionary zebrafish model to gain more insight into bone diseases
August 14, 2018 - Researchers discover secret communication hotline between breast cancers and normal cells
August 14, 2018 - Study examines how a person adapts to visual field loss after stroke
August 14, 2018 - Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells
August 14, 2018 - Reducing opioid prescriptions for one operation can also spill over to other procedures
August 14, 2018 - E-cigarettes not so safe but still better than cigarettes
August 14, 2018 - Researchers find link between common ‘harmless’ virus and cardiovascular damage
August 14, 2018 - Initiation of PIMs associated with higher risk of fracture-specific hospitalizations and mortality
August 14, 2018 - Genetically modified mosquitoes and special bed nets help tackle deadly diseases
UM SOM learn about unearths intriguing courting between sleep, cognition and kynurenine compound

UM SOM learn about unearths intriguing courting between sleep, cognition and kynurenine compound

image_pdfDownload PDFimage_print

Greater than three.2 million American citizens be afflicted by schizophrenia; about 100,000 persons are newly identified once a year. The illness contains quite a lot of signs together with visible and auditory hallucinations, cognitive issues and motivational problems. A key factor with the illness, and one who will get much less consideration than different signs, is cognitive issues. Many with the illness have hassle with finding out and reminiscence. For lots of, that is the primary signal of the illness.

A brand new learn about by means of researchers on the College of Maryland Faculty of Medication (UM SOM) has discovered intriguing hyperlinks between sleep, cognition and a compound known as kynurenine. Those hyperlinks may just remove darkness from the mechanism that reasons cognitive issues amongst the ones with the illness, and may just level how to new therapies to scale back one of the vital illness’s signs.

The findings had been printed these days within the magazine Sleep. The learn about is the primary to remove darkness from intimately the hyperlinks between kynurenine, its metabolite kynurenic acid, sleep and cognition.

“No person has seemed carefully on the courting between sleep and the kynurenine pathway prior to,” mentioned Ana Pocivavsek, a researcher on the UM SOM Maryland Psychiatric Analysis Heart (MPRC) and an assistant professor within the Division of Psychiatry. “This analysis establishes a transparent hyperlink between elevations in kynurenine and sleep issues.”

Lately, scientists have recognized kynurenic acid as a possible key participant in schizophrenia. Kynurenic acid is a neuroactive metabolite of kynurenine this is shaped within the mind. Other people with schizophrenia have upper than standard ranges of kynurenic acid of their brains. Scientists have theorized that those increased ranges could be hooked up with a spread of signs noticed within the illness, together with issues of finding out and reminiscence.

The mechanisms underlying the cognitive impairments in sufferers, on the other hand, have remained unclear. Dr. Pocivavsek and her colleagues suspected that an interaction between increased kynurenic acid and sleep may just play a task. There may be a large number of proof in each people and animals that sleep disorder ends up in issues of finding out and reminiscence. As well as, researchers and clinicians have lengthy famous that folks with schizophrenia steadily have issues of sleep as smartly.

For those experiments, she and her colleagues studied rats. They made comparisons within the habits of rats with greater kynurenic acid of their brains to animals with standard ranges of the compound. They hooked up the animals’ brains to a tool that measured the volume and high quality of sleep, and located that the animals with upper ranges of kynurenic acid had considerably much less speedy eye motion, or REM, sleep. That is the sleep section through which goals happen, and it’s regarded as crucial for the consolidation of earlier finding out.

The researchers discovered that the gang with top kynurenic acid additionally had issues of finding out. To check this, they position rats in a field and shine mild into the field. On one aspect of the field there may be a gap right into a darker house. Rats are nocturnal animals, and like the darkish, so the animals in most cases run to the darkish house. As soon as on this house, they obtain a small electrical surprise. When the experiment is repeated tomorrow, standard animals don’t run to the darker house, remembering the surprise from the day prior to. By way of comparability, animals with greater ranges of top kynurenic acid, and thus impaired sleep, don’t take into account the surprise from the day prior to, and run into the darkish house. In different phrases they didn’t be told from the day gone by’s enjoy.

“What we are beginning to take into consideration is that kynurenic acid disrupts sleep, which then disrupts cognition,” she mentioned. Then again, there are different probabilities, she says: it can be that disruptions in sleep reason greater kynurenic acid, which then ends up in cognitive issues. “It isn’t transparent which occurs first,” she says. “That may be a in point of fact attention-grabbing query, and one who we’re investigating.”

Dr. Pocivavsek and different researchers theorize that lowering kynurenic acid may just scale back issues of sleep and cognition in sufferers with schizophrenia. “We unquestionably imagine that prime ranges of kynurenic acid are a the most important side of schizophrenia,” she says.

The analysis supplies extra reason why to increase medications that scale back kynurenic acid ranges within the mind. One key chance is to inhibit an enzyme known as kynurenine aminotransferase II, or KAT II, which converts kynurenine to kynurenic acid. The use of compounds that inhibit this enzyme, researchers had been in a position to scale back the volume of kynurenic acid within the mind. Over time, quite a lot of pharmaceutical firms have labored to increase inhibitors of KAT II that may achieve the mind, and can be secure and efficient in people. Dr. Pocivavsek’s analysis supplies proof that this way has scientific possible.

“This learn about provides to the proof that prime ranges of kynurenic acid give a contribution to cognitive disorder,” she says. “If we will be able to get a hold of techniques to scale back the ones ranges, we could possibly scale back those signs for sufferers.”


Tagged with:

About author

Related Articles